M 520 ß-L-2'-Deoxyuridine Non-labeled |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
| Solid | 1 mg $215 |
| Screw cap v-vial | 5 mg $565 |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
M 1717 ß-L-2'-Deoxyuridine Non-labeled |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
| Solid | Please Inquire for Pricing |
| Screw cap v-vial | |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1806 ß-L-2'-Deoxyuridine, [3H]- |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| ≥ 5 Ci(185-370 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1496 2'-Deoxyuridine, [14C(U)]- |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Aqueous solution | |
| ≥ 390 mCi(14.4 GBq)/mmol, 100 µCi/ml | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 119 2'-Deoxyuridine, [2-14C]- Click here for Typical Certificate of Analysis |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 100 µCi/ml | 10 μCi (370 kBq) $1240 |
| ≥ 45 mCi(1.665 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial | 250 µCi (9.25 MBq) $5155 |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1103 2'-Deoxyuridine, [6-14C]- |
|
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 100 µCi/ml | |
| ≥ 45 mCi(1.665 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 648 2'-Deoxyuridine, [5-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 1 mCi/ml | |
| ≥ 5 Ci(185GBq)/mmol | 250 µCi (9.25 MBq) $1970 |
| NextGen V-Vial | 1 mCi (37 MBq) $2415 |
| M.W. 228.20 | 5 mCi (185 MBq) $3215 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 649 2'-Deoxyuridine, [6-3H]- Click here for Typical Certificate of Analysis |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 1 mCi/ml | |
| > 15Ci(0.555 TBq)/mmol | 250 µCi (9.25 MBq) $1970 |
| NextGen V-Vial | 1 mCi (37 MBq) $2780 |
| M.W. 228.20 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
